177 related articles for article (PubMed ID: 27120789)
1. The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.
Pandya V; Glubrecht D; Vos L; Hanson J; Damaraju S; Mackey J; Hugh J; Goping IS
Oncotarget; 2016 May; 7(22):33272-85. PubMed ID: 27120789
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).
Zhou H; Zhang Y; Fu Y; Chan L; Lee AS
J Biol Chem; 2011 Jul; 286(29):25687-96. PubMed ID: 21622563
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.
Ruiz Esparza-Garrido R; Torres-Márquez ME; Viedma-Rodríguez R; Velázquez-Wong AC; Salamanca-Gómez F; Rosas-Vargas H; Velázquez-Flores MÁ
Tumour Biol; 2016 May; 37(5):6749-59. PubMed ID: 26662110
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the protein expression of GRP78 and BIK/NBK with prognostic markers in patients with breast cancer and neoadjuvant chemotherapy.
López-Muñoz E; Corres-Molina M; García-Hernández N
J Obstet Gynaecol; 2020 Apr; 40(3):419-426. PubMed ID: 31635499
[TBL] [Abstract][Full Text] [Related]
5. BIK and GRP78 protein expression as possible markers of response to preoperative chemotherapy and survival in breast cancer.
María Teresa de Jesús CD; Agni Jaim MG; Cindy Karina VV; Víctor Alberto OC; Nicolás RT; Verónica GO; Fabio Abdel SG; Patricia PS; Sergio FH; Eunice LM
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):245-252. PubMed ID: 33678323
[TBL] [Abstract][Full Text] [Related]
6. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
Yang Y; Qian J; Xiang Y; Chen Y; Qu J
Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
[TBL] [Abstract][Full Text] [Related]
8. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
9. Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death.
Elangovan B; Chinnadurai G
J Biol Chem; 1997 Sep; 272(39):24494-8. PubMed ID: 9305912
[TBL] [Abstract][Full Text] [Related]
10. Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.
Brosseau C; Dousset C; Touzeau C; Maïga S; Moreau P; Amiot M; Le Gouill S; Pellat-Deceunynck C
Cell Death Dis; 2014 Aug; 5(8):e1389. PubMed ID: 25165875
[TBL] [Abstract][Full Text] [Related]
11. The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.
Hur J; Chesnes J; Coser KR; Lee RS; Geck P; Isselbacher KJ; Shioda T
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2351-6. PubMed ID: 14983013
[TBL] [Abstract][Full Text] [Related]
12. Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.
Mathai JP; Germain M; Marcellus RC; Shore GC
Oncogene; 2002 Apr; 21(16):2534-44. PubMed ID: 11971188
[TBL] [Abstract][Full Text] [Related]
13. BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer.
Pandya V; Githaka JM; Patel N; Veldhoen R; Hugh J; Damaraju S; McMullen T; Mackey J; Goping IS
Cell Death Dis; 2020 Jun; 11(6):448. PubMed ID: 32528057
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
15. Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications.
Hatzimichael E; Dasoula A; Kounnis V; Benetatos L; Lo Nigro C; Lattanzio L; Papoudou-Bai A; Dranitsaris G; Briasoulis E; Crook T
Leuk Lymphoma; 2012 Sep; 53(9):1709-13. PubMed ID: 22288719
[TBL] [Abstract][Full Text] [Related]
16. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.
Radetzki S; Köhne CH; von Haefen C; Gillissen B; Sturm I; Dörken B; Daniel PT
Oncogene; 2002 Jan; 21(2):227-38. PubMed ID: 11803466
[TBL] [Abstract][Full Text] [Related]
17. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
18. Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.
Wang C; Tran-Thanh D; Moreno JC; Cawthorn TR; Jacks LM; Wang DY; McCready DR; Done SJ
Breast Cancer Res Treat; 2011 Sep; 129(2):373-86. PubMed ID: 21046228
[TBL] [Abstract][Full Text] [Related]
19. BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients.
López-Muñoz E; Hernández-Zarco A; García-Hernández N; Alvarado-Cabrero I; Zarco-Espinosa G; Salamanca-Gómez F; Arenas-Aranda D
Clin Transl Oncol; 2012 Aug; 14(8):586-91. PubMed ID: 22855140
[TBL] [Abstract][Full Text] [Related]
20. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.
Reedijk M; Pinnaduwage D; Dickson BC; Mulligan AM; Zhang H; Bull SB; O'Malley FP; Egan SE; Andrulis IL
Breast Cancer Res Treat; 2008 Oct; 111(3):439-48. PubMed ID: 17990101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
